Pathological stage in the untreated and treated patients with clinical stage C disease
| Pathological stage | Surgery only (%) | 12 weeks of NHT (%) | 24 weeks of NHT (%) |
|---|---|---|---|
| Chi square=22.152; p=0.001. Untreated versus 12 weeks of NHT: χ2=5.221; p=0.207 (not significant (NS)). Untreated versus 24 weeks of NHT: χ2=20.024; p<0.001. 12 weeks of NHT versus 24 weeks of NHT: χ2=9.266; p=0.033 (NS). | |||
| NHT, neoadjuvant hormonal treatment. | |||
| B | 3 (10.4%) | 11 (31.4%) | 19 (61.2%) |
| C1 | 11 (37.9%) | 13 (37.1%) | 3 (9.7%) |
| C2 | 5 (17.2%) | 5 (14.3%) | 6 (19.4%) |
| D1 | 10 (34.5%) | 6 (17.2%) | 3 (9.7%) |
| Total | 29 | 35 | 31 |